Clinical Trial: Topical 0.4% Ketorolac and Vitreoretinal Surgery

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Topical 0.4% Ketorolac for the Inhibition of Miosis During Vitreoretinal Surgery: a Randomized, Placebo-controlled, Double-masked Study

Brief Summary: To determine whether use of topical 0.4% ketorolac has any effect on pupil size during vitreoretinal surgery.

Detailed Summary: Other outcomes will be to assess postoperative pain and inflammation and visual acuity.
Sponsor: Emory University

Current Primary Outcome: Change in pupil size during vitreoretinal surgery [ Time Frame: Surgery ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Postoperative pain and inflammation [ Time Frame: 1 day ]

Original Secondary Outcome: Same as current

Information By: Emory University

Dates:
Date Received: December 17, 2007
Date Started: November 2006
Date Completion:
Last Updated: May 12, 2014
Last Verified: May 2014